全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Oesophageal Mycosis: Epidemiological and Clinical Aspects and Risk Factors for Occurrence in the Digestive Endoscopy Unit of the Donka National Hospital, Conakry CHU

DOI: 10.4236/ojgas.2024.142004, PP. 31-40

Keywords: Endoscopy, CHU Conakry, Risk Factors, Immunosuppression, Oesophageal Mycosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Oesophageal mycosis (OM) is one of the most common opportunistic infections in patients infected with HIV (Human Immunodeficiency Virus). However, this condition is increasingly observed in immunocompetent subjects. The aim of this study was to determine the endoscopic prevalence, clinical characteristics and risk factors for the occurrence of oesophageal mycosis in our department. Patients and Method: This was a prospective cross-sectional study of all patients who underwent oeso-gastroduodenal fibroscopy during the period from 1st January to 31st December 2022, i.e. one year, at the digestive endoscopy unit of the hepato-gastroenterology department of the Donka CHU national hospital in Conakry. All patients found to have oesophageal mycosis by FOGD were included. The endoscopy was performed using appropriate equipment: A Fujinon 4400 video endoscopy column; Three Fujinon EG 590 video gastroscopes; A hoover; Data were collected using a pre-established survey form and analysed using Epi info software version 6.0.4; Pearson’s Chi2 test as a test of independence and the exact 5% threshold ficher test. Results: Out of 1343 upper gastrointestinal endoscopies performed, 107 cases of oesophageal mycosis were found, representing a prevalence of 7.96%. The mean age was 40 years, with a male predominance of 55.42%. The sex ratio M/F was 1.24. The 45 and over age group was the most affected, with a prevalence of 40.43%, followed by the [35 - 45] age group, with a prevalence of 22.43%. Clinical symptoms were dominated by epigastralgia in 74.76% of cases, followed by odynophagia in 37.38% of cases, nausea and vomiting in 28.03% of cases, and pyrosis in 26.16% of cases. Oesophageal mycosis without oesophagitis was the most common endoscopic finding in 70% of cases. The main associated endoscopic lesions were erythemato-erosive and congestive gastropathy in 28.03% of cases, peptic oesophagitis (9.34%) and gastric ulcer (5.60%). The main risk factors found were positive HIV serology in 39.25% of cases, and diabetes in 24.30% of cases, with a statistically significant relationship of 0.02 and 0.01 respectively. Conclusion: Oesophageal mycosis is the most common opportunistic infection in patients with impaired cellular immunity. The prevalence of oesophageal mycosis in our series was 7.96%. This study enabled us to identify the main risk factors for the occurrence of oesophageal mycosis. Our country needs to step up its programme to combat and prevent

References

[1]  Laine, L. and Bonaci, M. (1994) Esophageal Diseases in Human Immunodeficiency Virus Infection. Archives of Internal Medicine, 154, 1577-1582.
https://doi.org/10.1001/archinte.1994.00420140042005
[2]  Thapa, B.R. and Kumar, L. (1989) Candida Esophagitis after Antibiotic Use. Indian Journal of Pediatrics, 56, 296-299.
https://doi.org/10.1007/BF02726633
[3]  Karmeli, Y., Stalnikowitz, R., Eliakim, R. and Rahav, G. (1995) Conventional Dose of Omeprazole Alters Gastric Flora. Digestive Diseases and Sciences, 40, 2070-2073.
https://doi.org/10.1007/BF02208680
[4]  Weerasuriya, N. and Snape, J. (2008) Esophageal Candidiasis in Elderly Patients: Risk Factors, Prevention and Management. Drugs Aging, 25, 119-130.
https://doi.org/10.2165/00002512-200825020-00004
[5]  Girard, P.M., Katlama, C. and Pialoux, G. (2007) VIH 2007. DOIN, Paris, 98-101.
[6]  Denis, B. and Lortholary, O. (2013) Pulmonary Fungal Infections in HIV-Positive Patients. Revue des Maladies Respiratoires, 30, 682-695.
https://doi.org/10.1016/j.rmr.2013.02.005
[7]  Lacassin, F. and Leport, C. (1995) Oropharyngeal and Intestinal Candidiasis in Patients Infected with the Human Immunodeficiency Virus. Infectious Diseases Medicine, 25, 40-43.
[8]  Delamares, J. (2011) Abridged Dictionary of Medical Terms. 5th Edition, Maloine, Paris, 201 p.
[9]  Faouzi, J. (1984) Endoscopic Aspects in Oesogastroduodenal Pathology in Senegalese Settings, Apropos of 3000 Examinations Carried out in 2 Years at the Dakar Hospital. Ph.D. Thesis, Cheick Anta Diop of Dakar, Dakar, 84 p.
[10]  Ibara, J.R., Moukassa, B. and Itoua-Ngaporo, A. (1993) Upper Gastrointestinal Pathology in the Congo Based on 2393 Endoscopies Performed at the Brazzaville University Hospital. Black African Medicine, 40, 97-100.
[11]  Kondé, A., Sidibé, L., Diarra, A., Fofana, Y., Samaké, D., Katilé, D., et al. (2023) Endoscopic Aspects of Oesophageal Pathologies in Mopti. Health Sciences and Diseases, 25, 150-152.
[12]  Allah-Kouadio, E., Koné, S., et al. (2015) HIV Prevalence in Subjects with Esophageal Mycosis. RevInt Sc Méd Abi-PRISM, 17, 77-79.
[13]  Mimidis, K., Papadopoulos, V., Margaritis, V., et al. (2005) Predisposing Factors and Clinical Symptoms in HIV-Negative Patients with Candida Esophagitis: Are They Always Present? International Journal of Clinical Practice, 59, 210-213.
https://doi.org/10.1111/j.1742-1241.2004.00249.x
[14]  Weerasuriya, N. and Snape, J. (2006) A Study of Candida Esophagitis in Early Patients Attending a District General Hospital in the UK. Diseases of the Esophagus, 19, 189-192.
https://doi.org/10.1111/j.1442-2050.2006.00563.x
[15]  Amri, M., Mouelhi, L., Mensi, A., et al. (2014) Mycotic Esophagitis—Prevalence and Risk Factors in HIV-Negative Subjects.
https://www.snfge.org/content/oesophagite-mycosique-prevalence-et-facteurs-d
[16]  Vidal, A., Pannain, V. and Bottino, A. (2007) Esophagitis in Patients with Acquired Human Immunodeficiency Syndrome: An Histological and Immunohistochemistry Study. Arquivos de Gastroenterologia, 44, 309-314.
https://doi.org/10.1590/S0004-28032007000400006
[17]  Bonacini, M., Terry, Y. and Loren, L. (1991) The Causes of Esophageal Symptoms in Human Immunodeficiency Virus Infection. A Prospective Study of 110 Patients. Archives of Internal Medicine, 151, 1567-1572.
https://doi.org/10.1001/archinte.1991.00400080067012
[18]  Ngatcha, G., Kabbaj, N., Salihoun, M., et al. (2014) Digestive Lesions Secondary to Acquired Immunodeficiency Syndrome. Hegel, 4, 22-27.
https://doi.org/10.3917/heg.041.0022
[19]  Redah, D., Kountse, A.Y., Agbo, K., et al. (2001) Is Endoscopic Diagnosis of Candida Albicans Oesophagitis Reliable? Gastroentérologie Clinique et Biologique, 25. 161-163.
[20]  Maiga, M.Y., Traore, H.A., Touré, T., et al. (1996) Study of Oesophagitis in Bamako, 228 Cases. Médecine D’Afrique Noire, 43, 228-231.
[21]  Ouattara, A., Allah Kouadio, E., Soro, D., et al. (2018) Etiological Profile of Esophagitis in the Endoscopic Unit of the Hospital and University Centre of Cocody-Abidjan Ivory Coast. RevInt Sc Méd Abi-PRISM, 20, 85-89.
[22]  Macroft, A., Oancea, C., Van Lunzen, J., et al. (2005) Decline in Esophageal Candidiasis and Use of Antimycotics in European Patients with HIV. American Journal of Gastroenterology, 100, 1446-1454.
https://doi.org/10.1111/j.1572-0241.2005.41949.x
[23]  Klein, R.S., Harris, C.A., Small, C.B., et al. (1984) Oral Candidiasis in High-Risk Patients as the Initial Manifestation of the Acquired Immunodeficiency Syndrome. The New England Journal of Medicine, 311, 354-358.
https://doi.org/10.1056/NEJM198408093110602
[24]  Choi, J.H. (2013) Prevalence and Risk Factors of Esophageal Candidiasis in Healthy Individuals: A Single Center Experience in Korea. Yonsei Medical Journal, 54, 160-165.
https://doi.org/10.3349/ymj.2013.54.1.160
[25]  Yakoob, J., Jafri, W. and Abid, S. (2003) Candida Esophagitis: Risk Factors in Non-HIV Population in Pakistan. World Journal of Gastroenterology, 9, 2328-2331.
https://doi.org/10.3748/wjg.v9.i10.2328

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133